SMAD2 and colorectal carcinoma: Compared with the si-CTBP1-AS2 group, the activation of the TGF-β1/SMAD2/3 pathway accelerated CRC cell proliferation (Figures 4B,C) and invasion (Figure 4E), while reducing the cell apoptosis (Figure 4D).